The concordance study of MMR status between MSI testing (FALCO) and immunohistochemistry method using RDKK kit

The concordance study of MMR status between MSI testing (FALCO) and immunohistochemistry method using RDKK kit - The concordance study of MMR status between MSI testing (FALCO) and immunohistochemistry method using RDKK kit

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042150

Enrollment

150

Registered

2020-10-18

Start date

2020-02-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Participate in GI-SCREEN MSI study 1)Patient who can provide written informed consent for secondary use of samples 2)Obtaining MMR status by PCR (FALCO) 3)Enough samples for the analysis in the study 2.Patients in National Cancer Center 1)Patient who can provide written informed consent for secondary use of samples 2)Obtaining MMR status by PCR (FALCO) or IHC method 3)Enough samples for the analysis in the study

Exclusion criteria

Exclusion criteria: 1)Patients who are unfit for the study as determined by the attending physician

Design outcomes

Primary

Measure	Time frame
Sensitivity and Specificity	—

Countries

Japan

Contacts

Public ContactSaori Mishima

National Cancer Center Hospital East Department of Gastroenterology and Gastrointestinal Oncology

smishima@east.ncc.go.jp04-7133-1111

Outcome results